(Q42656176)

4 November 2017

title

Alzheimer's disease research and development: a call for a new research roadmap (English)

1 reference

4 November 2017

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754377%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Alan-J. Cross

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754377%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Magali Haas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754377%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Sam Gandy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754377%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Darryle D Schoepp

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754377%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Reisa A Sperling

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754377%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Howard Fillit

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754377%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Diana L van de Hoef

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754377%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Sonya Dougal

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754377%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Jeffrey S Nye

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754377%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

One Mind for Research and the New York Academy of Sciences

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754377%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Richard Mayeux

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754377%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

English

0 references

publication date

1 April 2014

1 reference

Annals of the New York Academy of Sciences

4 November 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754377%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

1313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754377%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

1-16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754377%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of dementia in the United States: the aging, demographics, and memory study.

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

The neuropathology of probable Alzheimer disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

Multiple brain pathologies in dementia are common

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

Helping caregivers of persons with dementia: which interventions work and how large are their effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

Caregiving as a risk factor for mortality: the Caregiver Health Effects Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

APOE {epsilon}4 and bapineuzumab: Infusing pharmacogenomics into Alzheimer disease therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

Intracranial injection of Gammagard, a human IVIg, modulates the inflammatory response of the brain and lowers Aβ in APP/PS1 mice along a different time course than anti-Aβ antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

IVIG immunotherapy protects against synaptic dysfunction in Alzheimer's disease through complement anaphylatoxin C5a-mediated AMPA-CREB-C/EBP signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

Intravenous immunglobulin binds beta amyloid and modifies its aggregation, neurotoxicity and microglial phagocytosis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424

Economic analysis of opportunities to accelerate Alzheimer's disease research and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12424